Fresenius Historical Balance Sheet

0H9X Stock

44.82 0.45 1.01%

Trend analysis of Fresenius Medical Care balance sheet accounts such as Short Long Term Debt Total of 8.6 B, Total Current Liabilities of 6.9 B or Total Stockholder Equity of 12 B provides information on Fresenius Medical's total assets, liabilities, and equity, which is the actual value of Fresenius Medical Care to its prevalent stockholders. By breaking down trends over time using Fresenius Medical balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Fresenius Medical Care latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Fresenius Medical Care is a good buy for the upcoming year.

Fresenius Medical Inventory

1.88 Billion

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Fresenius Medical Care. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Fresenius Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Fresenius Medical Care at a specified time, usually calculated after every quarter, six months, or one year. Fresenius Medical Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Fresenius Medical and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Fresenius currently owns. An asset can also be divided into two categories, current and non-current.

Fresenius Medical Balance Sheet Chart

At this time, Fresenius Medical's Cash is comparatively stable compared to the past year. Cash And Short Term Investments is likely to gain to about 1.5 B in 2024, whereas Short and Long Term Debt Total is likely to drop slightly above 8.6 B in 2024.

Total Assets Total Current Liabilities Total Stockholder Equity Other Assets

Total Assets

Total assets refers to the total amount of Fresenius Medical assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Fresenius Medical Care books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Fresenius Medical balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Fresenius Medical Care are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Most accounts from Fresenius Medical's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Fresenius Medical Care current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Fresenius Medical Care. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2019	2020	2023	2024 (projected)
Short and Long Term Debt Total	10.5B	10.7B	12.3B	8.6B
Total Assets	32.9B	31.7B	36.4B	30.9B

Short Long Term Debt Total Total Assets

Fresenius Medical balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Total Current Liabilities	Total Stockholder Equity	Retained Earnings	Cash	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Good Will	Short Term Investments	Capital Surpluse	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Treasury Stock	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Other Current Liab	Other Liab	Net Tangible Assets
Total Assets		0.95	0.92	0.88	0.93	0.22	0.93	0.45	0.32	0.92	0.76	-0.36	-0.91	0.93	0.84	-0.22	0.99	0.82	-0.92	-0.47	0.97	-0.66	0.98	0.89	0.88	-0.93
Short Long Term Debt Total	0.95		0.79	0.7	0.83	-0.03	0.82	0.6	0.06	0.78	0.69	-0.22	-0.88	0.89	0.85	-0.21	0.99	0.69	-0.91	-0.61	0.99	-0.53	0.96	0.88	0.84	-0.91
Total Current Liabilities	0.92	0.79		0.93	0.93	0.46	0.96	0.19	0.53	0.94	0.65	-0.52	-0.83	0.85	0.65	-0.25	0.86	0.84	-0.86	-0.29	0.84	-0.66	0.9	0.82	0.75	-0.87
Total Stockholder Equity	0.88	0.7	0.93		0.9	0.59	0.92	0.12	0.68	0.95	0.68	-0.52	-0.78	0.81	0.67	-0.22	0.8	0.87	-0.76	-0.18	0.76	-0.7	0.82	0.75	0.77	-0.78
Retained Earnings	0.93	0.83	0.93	0.9		0.5	0.99	0.19	0.55	0.93	0.53	-0.59	-0.94	0.93	0.83	-0.39	0.89	0.86	-0.91	-0.43	0.88	-0.66	0.94	0.92	0.88	-0.89
Cash	0.22	-0.03	0.46	0.59	0.5		0.52	-0.65	0.97	0.45	-0.12	-0.63	-0.26	0.27	0.16	-0.43	0.09	0.46	-0.21	0.31	0.07	-0.24	0.21	0.22	0.22	-0.2
Other Assets	0.93	0.82	0.96	0.92	0.99	0.52		0.15	0.58	0.91	0.53	-0.55	-0.91	0.89	0.79	-0.41	0.88	0.84	-0.91	-0.37	0.88	-0.63	0.94	0.89	0.82	-0.9
Long Term Debt	0.45	0.6	0.19	0.12	0.19	-0.65	0.15		-0.5	0.28	0.69	0.44	-0.43	0.47	0.47	0.43	0.54	0.35	-0.3	-0.74	0.51	-0.4	0.39	0.47	0.53	-0.32
Cash And Short Term Investments	0.32	0.06	0.53	0.68	0.55	0.97	0.58	-0.5		0.53	0.03	-0.49	-0.34	0.36	0.24	-0.31	0.19	0.59	-0.24	0.24	0.16	-0.32	0.28	0.3	0.31	-0.25
Net Receivables	0.92	0.78	0.94	0.95	0.93	0.45	0.91	0.28	0.53		0.73	-0.51	-0.84	0.92	0.69	-0.08	0.86	0.93	-0.79	-0.34	0.82	-0.74	0.87	0.82	0.86	-0.8
Good Will	0.76	0.69	0.65	0.68	0.53	-0.12	0.53	0.69	0.03	0.73		-0.04	-0.58	0.64	0.53	0.3	0.75	0.65	-0.54	-0.39	0.68	-0.72	0.64	0.57	0.66	-0.6
Short Term Investments	-0.36	-0.22	-0.52	-0.52	-0.59	-0.63	-0.55	0.44	-0.49	-0.51	-0.04		0.41	-0.37	-0.31	0.59	-0.29	-0.3	0.5	-0.06	-0.29	0.38	-0.42	-0.38	-0.36	0.45
Capital Surpluse	-0.91	-0.88	-0.83	-0.78	-0.94	-0.26	-0.91	-0.43	-0.34	-0.84	-0.58	0.41		-0.95	-0.92	0.27	-0.9	-0.83	0.9	0.72	-0.89	0.76	-0.92	-0.99	-0.96	0.89
Inventory	0.93	0.89	0.85	0.81	0.93	0.27	0.89	0.47	0.36	0.92	0.64	-0.37	-0.95		0.85	-0.12	0.92	0.91	-0.84	-0.62	0.9	-0.68	0.91	0.94	0.96	-0.83
Other Current Assets	0.84	0.85	0.65	0.67	0.83	0.16	0.79	0.47	0.24	0.69	0.53	-0.31	-0.92	0.85		-0.4	0.85	0.68	-0.83	-0.7	0.84	-0.65	0.85	0.91	0.92	-0.8
Other Stockholder Equity	-0.22	-0.21	-0.25	-0.22	-0.39	-0.43	-0.41	0.43	-0.31	-0.08	0.3	0.59	0.27	-0.12	-0.4		-0.2	0.05	0.42	-0.07	-0.26	-0.08	-0.33	-0.28	-0.13	0.33
Total Liab	0.99	0.99	0.86	0.8	0.89	0.09	0.88	0.54	0.19	0.86	0.75	-0.29	-0.9	0.92	0.85	-0.2		0.77	-0.92	-0.55	0.99	-0.61	0.98	0.89	0.87	-0.93
Total Current Assets	0.82	0.69	0.84	0.87	0.86	0.46	0.84	0.35	0.59	0.93	0.65	-0.3	-0.83	0.91	0.68	0.05	0.77		-0.64	-0.45	0.71	-0.73	0.75	0.82	0.87	-0.66
Treasury Stock	-0.92	-0.91	-0.86	-0.76	-0.91	-0.21	-0.91	-0.3	-0.24	-0.79	-0.54	0.5	0.9	-0.84	-0.83	0.42	-0.92	-0.64		0.51	-0.94	0.6	-0.97	-0.88	-0.8	0.99
Short Term Debt	-0.47	-0.61	-0.29	-0.18	-0.43	0.31	-0.37	-0.74	0.24	-0.34	-0.39	-0.06	0.72	-0.62	-0.7	-0.07	-0.55	-0.45	0.51		-0.53	0.61	-0.51	-0.74	-0.72	0.49
Intangible Assets	0.97	0.99	0.84	0.76	0.88	0.07	0.88	0.51	0.16	0.82	0.68	-0.29	-0.89	0.9	0.84	-0.26	0.99	0.71	-0.94	-0.53		-0.54	0.98	0.88	0.84	-0.94
Common Stock	-0.66	-0.53	-0.66	-0.7	-0.66	-0.24	-0.63	-0.4	-0.32	-0.74	-0.72	0.38	0.76	-0.68	-0.65	-0.08	-0.61	-0.73	0.6	0.61	-0.54		-0.61	-0.75	-0.79	0.63
Property Plant Equipment	0.98	0.96	0.9	0.82	0.94	0.21	0.94	0.39	0.28	0.87	0.64	-0.42	-0.92	0.91	0.85	-0.33	0.98	0.75	-0.97	-0.51	0.98	-0.61		0.91	0.85	-0.97
Other Current Liab	0.89	0.88	0.82	0.75	0.92	0.22	0.89	0.47	0.3	0.82	0.57	-0.38	-0.99	0.94	0.91	-0.28	0.89	0.82	-0.88	-0.74	0.88	-0.75	0.91		0.94	-0.86
Other Liab	0.88	0.84	0.75	0.77	0.88	0.22	0.82	0.53	0.31	0.86	0.66	-0.36	-0.96	0.96	0.92	-0.13	0.87	0.87	-0.8	-0.72	0.84	-0.79	0.85	0.94		-0.79
Net Tangible Assets	-0.93	-0.91	-0.87	-0.78	-0.89	-0.2	-0.9	-0.32	-0.25	-0.8	-0.6	0.45	0.89	-0.83	-0.8	0.33	-0.93	-0.66	0.99	0.49	-0.94	0.63	-0.97	-0.86	-0.79

Click cells to compare fundamentals

Fresenius Medical Account Relationship Matchups

Fresenius Medical balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	24.0B	26.2B	32.9B	31.7B	36.4B	30.9B
Short Long Term Debt Total	5.8B	5.0B	10.5B	10.7B	12.3B	8.6B
Total Current Liabilities	7.1B	6.1B	7.3B	6.5B	7.4B	6.9B
Total Stockholder Equity	9.8B	11.8B	12.0B	11.2B	12.9B	12.0B
Retained Earnings	9.5B	10.3B	10.8B	10.7B	12.3B	9.9B
Cash	358.0M	1.3B	239.0M	334.7M	384.9M	503.2M
Other Assets	1.1B	1.1B	1.2B	1.1B	1.3B	1.1B
Long Term Debt	5.8B	5.0B	6.5B	6.8B	7.8B	6.8B
Cash And Short Term Investments	993.6M	2.3B	1.1B	1.2B	1.4B	1.5B
Net Receivables	4.0B	3.6B	3.9B	4.0B	4.6B	4.1B
Good Will	12.1B	12.2B	14.0B	13.0B	14.9B	14.1B
Short Term Investments	15.5M	119.5M	133.3M	161.7M	145.5M	108.9M
Capital Surpluse	4.0B	3.9B	3.6B	2.9B	2.6B	2.9B
Inventory	1.7B	1.9B	2.0B	2.3B	2.6B	1.9B
Other Current Assets	306.6M	462.2M	346.3M	370.8M	426.5M	361.6M
Other Stockholder Equity	(1.0B)	(2.2B)	(1.3B)	(388.5M)	(349.6M)	(367.1M)
Total Liab	14.2B	14.5B	21.0B	20.5B	23.5B	18.8B
Total Current Assets	7.2B	7.3B	8.0B	8.2B	9.4B	8.1B
Short Term Debt	769.3M	1.4B	1.2B	79.3M	71.3M	67.8M
Intangible Assets	683.1M	681.3M	1.4B	1.4B	1.6B	1.1B
Common Stock	304.4M	292.9M	293.0M	293.4M	264.1M	240.8M
Property Plant Equipment	8.5B	8.2B	8.6B	8.3B	9.6B	7.0B
Other Current Liab	1.8B	2.4B	2.6B	2.3B	2.7B	2.4B
Other Liab	2.1B	2.6B	2.4B	2.7B	3.1B	2.6B
Net Tangible Assets	(3.5B)	(3.1B)	(3.1B)	(3.3B)	(3.0B)	(3.1B)
Accounts Payable	756.2M	794.9M	818.5M	892.6M	1.0B	872.3M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

TITAN	Titan Company Limited
U	Unity Software
PAYC	Paycom Soft

Additional Tools for Fresenius Stock Analysis

When running Fresenius Medical's price analysis, check to measure Fresenius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius Medical is operating at the current time. Most of Fresenius Medical's value examination focuses on studying past and present price action to predict the probability of Fresenius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius Medical's price. Additionally, you may evaluate how the addition of Fresenius Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC